Prognostic significance and response to immune checkpoint inhibitors of RIPK3, MLKL and necroptosis in non-small cell lung cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Prognostic significance and response to immune checkpoint inhibitors of RIPK3, MLKL and necroptosis in non-small cell lung cancer ; volume:14 ; number:1 ; day:16 ; month:9 ; year:2024 ; pages:1-17 ; date:12.2024
Scientific reports ; 14, Heft 1 (16.9.2024), 1-17, 12.2024
- Urheber
-
Duangthim, Nattaya
Lomphithak, Thanpisit
Saito-Koyama, Ryoko
Miki, Yasuhiro
Inoue, Chihiro
Sato, Ikuro
Miyauchi, Eisaku
Abe, Jiro
Sasano, Hironobu
Jitkaew, Siriporn
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-72545-2
- URN
-
urn:nbn:de:101:1-2411292119113.951181676071
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Duangthim, Nattaya
- Lomphithak, Thanpisit
- Saito-Koyama, Ryoko
- Miki, Yasuhiro
- Inoue, Chihiro
- Sato, Ikuro
- Miyauchi, Eisaku
- Abe, Jiro
- Sasano, Hironobu
- Jitkaew, Siriporn
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic significance of CD276 in non-small cell lung cancer
Prognostic significance of CD44s expression in resected non-small cell lung cancer
Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer
Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer
Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer
Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis
Prognostic significance of blood-based PD-L1 analysis in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis
Prognostic Significance of Mean Platelet Volume on Local Advanced Non-Small Cell Lung Cancer Managed with Chemoradiotherapy
Prognostic significance of 4R lymph node dissection in patients with right primary non-small cell lung cancer
HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors
Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma
Prognostic significance of CD276 in non-small cell lung cancer
Prognostic significance of CD44s expression in resected non-small cell lung cancer
Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer
Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer
Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer
Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis
Prognostic significance of blood-based PD-L1 analysis in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis
Prognostic Significance of Mean Platelet Volume on Local Advanced Non-Small Cell Lung Cancer Managed with Chemoradiotherapy
Prognostic significance of 4R lymph node dissection in patients with right primary non-small cell lung cancer
HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors
Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma
Prognostic significance of CD276 in non-small cell lung cancer
Prognostic significance of CD44s expression in resected non-small cell lung cancer
Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer
Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer
Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer
Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis
Prognostic significance of blood-based PD-L1 analysis in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis
Prognostic Significance of Mean Platelet Volume on Local Advanced Non-Small Cell Lung Cancer Managed with Chemoradiotherapy
Prognostic significance of 4R lymph node dissection in patients with right primary non-small cell lung cancer
HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors